Nucala 40 mg/.4mL
mepolizumab · INJECTION, SOLUTION · GlaxoSmithKline LLC
Nucala (mepolizumab) is an injectable medication that works by blocking interleukin-5, a protein involved in inflammation, and is used to treat certain types of asthma and eosinophilic conditions. It is given as a subcutaneous injection and requires a prescription from your doctor.
Key Facts
- Brand Name
- Nucala
- Generic Name
- mepolizumab
- NDC Code (Product)
0173-0904- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 40 mg/.4mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761122
- Drug Class
- Interleukin-5 Antagonist [EPC]
- Marketing Start
- 01/22/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Nucala used for?
Nucala (mepolizumab) is an injectable medication that works by blocking interleukin-5, a protein involved in inflammation, and is used to treat certain types of asthma and eosinophilic conditions. It is given as a subcutaneous injection and requires a prescription from your doctor.
Is Nucala a controlled substance?
Nucala is not classified as a controlled substance by the DEA.
What is the generic name for Nucala?
The generic name for Nucala is mepolizumab. There are no other listed brand versions of mepolizumab.
What is the NDC code for Nucala 40 mg/.4mL?
The NDC (National Drug Code) for Nucala 40 mg/.4mL is 0173-0904, listed by GlaxoSmithKline LLC.
Other Nucala Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)